The Future Looks Bright for Genetic Medicine

Today, gene therapy, genomics, and stem cell therapy are considered to be discrete fields of research.

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of Ronald Crystal

Today, gene therapy, genomics, and stem cell therapy are considered to be discrete fields of research. I believe that within 20 years, these three fields will team up to form a new medical specialty: genetic medicine.

These worlds are going to come together because they have so much to offer one another. Genetic transfer will be useful for instructing stem cells to differentiate, and it may enhance their therapeutic potential or control their possible side effects. Stem cells may be the ultimate vehicle to deliver genetic therapy, solving many of the problems that hamper current vectors. Stem cells home to a specific organ, and thus may be able to carry a gene to a specific target, without the immune system activation that can occur with viral vectors. Genomics may supply the specific data to both engineer and control stem cells, thus providing the underpinnings of genetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ronald Crystal

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo